Drug Delivery News
Nigeria Become First Country to Introduce New Meningitis Vaccine
In a historic move, Nigeria has become the first country in the world to roll out a new vaccine (called Men5CV) recommended by the World Health Organization, which protects people against five strains of the meningococcus bacteria. Read more
15 Apr 2024
Actylis and Novo Nordisk Pharmatech to Partner
Actylis and Novo Nordisk Pharmatech A/S have entered into an agreement for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland. Read more
25 Mar 2024
Orchard Therapeutics Receives FDA Approval of Lenmeldy
Orchard Therapeutics, recently acquired by Kyowa Kirin, have announced the U.S. FDA has approved Lenmeldy for the treatment of children with early-onset—metachromatic leukodystrophy. Read more
19 Mar 2024
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Ricoh Company, Ltd. have announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics. Read more
13 Mar 2024
Pfizer Oncology Hosts Innovation Day
Pfizer Inc. has outlined its strategic priorities for the newly formed Oncology organisation — and how its pipeline, Oncology expertise, and anticipated near- and mid-term catalysts are expected to position the company to grow strongly. Read more
1 Mar 2024
NorthSea Therapeutics Initiates Phase 2A Trial of Orziloben
NorthSea Therapeutics B.V. have announced the dosing of the first patient in its Phase 2a clinical trial of Orziloben (NST-6179) in intestinal failure-associated liver disease. Read more
21 Feb 2024
Pharmaceutical Drugs Innovations: Revolutionising Biological Drug Delivery
Professor Afzal R Mohammed, Professor of Pharmaceutics at Aston University and advisor to Max Bio+, explores two promising advancements being explored that could revolutionise biological drug delivery: liquid-based delivery and inhalation. Read more
13 Dec 2023
Innovation in Inhalation: The Future of Drug Delivery
Broughton's new inhalation testing service propels inhaled drug delivery into an innovative future. Read more
19 Jun 2023
Broughton speaks to EPM on the latest in inhaled medicines testing
EPM speaks to Chris Allen, CEO of scientific consultancy and Contract Research Organisation (CRO) Broughton, which has just launched a new inhalation testing service. Read more
8 Jun 2023
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Aramex Scoop Sustainability Award
Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Berry Global Invests to Increase Production Capacity
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Regeneron and Mammoth Biosciences to Collaborate
Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration to research, develop and commercialise in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. Read more
26 Apr 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Novartis Radioligand Therapy Lutathera FDA Approved
Novartis have announced that the FDA have approved Lutathera for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumours. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Owlstone Medical Secures $6.5 Million to Support Development
Owlstone Medical have announced it has secured funding from the Bill & Melinda Gates Foundation. Read more
25 Apr 2024
Pharma Manufacturing News + Pharma Finance and Investment News
MHRA Approves YORVIPATH
Ascendis Pharma have announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for YORVIPATH. Read more
25 Apr 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25